​

Praxis Precision Medicines (PRAX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

PRAX Stock Forecast

Praxis Precision Medicines (PRAX) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $607.15, with a high of $1,201.00 and a low of $162.00. This represents a 144.84% increase from the last price of $247.98.

- $300 $600 $900 $1 $1 High: $1201 Avg: $607.15 Low: $162 Last Closed Price: $247.98

PRAX Stock Rating

Praxis Precision Medicines stock's rating consensus is Buy, based on 16 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (75.00%), 3 Hold (18.75%), 1 Sell (6.25%), and 0 Strong Sell (0.00%).

Buy
Total 16 0 1 3 12 Strong Sell Sell Hold Buy Strong Buy

PRAX Price Target Upside V Benchmarks

TypeNameUpside
StockPraxis Precision Medicines144.84%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts91344
Avg Price Target$685.89$616.23$498.16
Last Closing Price$247.98$247.98$247.98
Upside/Downside176.59%148.50%100.89%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2621311-17
May, 2621311-17
Apr, 2621211-16
Mar, 2621311-17
Feb, 2621211-16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 02, 2026Truist Financial$616.00$306.06101.27%148.41%
Jun 02, 2026Wedbush$162.00$335.16-51.66%-34.67%
Jun 02, 2026Jay OlsonOppenheimer$650.00$335.1693.94%162.12%
Jun 02, 2026Robert W. Baird$400.00$335.1619.35%61.30%
Jun 02, 2026H.C. Wainwright$1.20K$335.16258.34%384.31%
Jun 02, 2026Kambiz YazdiBTIG$810.00$335.16141.68%226.64%
Jun 02, 2026David HoangDeutsche Bank$374.00$335.1611.59%50.82%
May 26, 2026Douglas TsaoH.C. Wainwright$1.25K$348.00257.76%402.06%
May 13, 2026Truist Financial$715.00$337.49111.86%188.33%
May 08, 2026Wedbush$166.00$339.13-51.05%-33.06%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 02, 2026Cowen & Co.BuyBuyhold
Jun 02, 2026OppenheimerOutperformOutperformhold
Jun 02, 2026BTIGBuyBuyhold
Jun 02, 2026Deutsche BankBuyBuyhold
May 26, 2026H.C. WainwrightBuyBuyhold
May 08, 2026WedbushUnderperformUnderperformhold
May 07, 2026JefferiesBuyBuyhold
Apr 15, 2026Deutsche BankBuyBuyhold
Apr 10, 2026Raymond JamesStrong Buyinitialise
Mar 09, 2026BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-18.69$-10.21$-13.48---
Avg Forecast$-20.43$-10.20$-11.47$-11.46$-9.52$-2.37
High Forecast$-14.03$-10.07$-8.88$-6.61$-3.02$-1.09
Low Forecast$-24.96$-10.32$-13.94$-19.33$-17.04$-3.75
Surprise %-8.52%0.10%17.52%---

Revenue Forecast

$0 $90M $180M $270M $360M $450M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.45M$8.55M----
Avg Forecast$1.90M$1.47M$967.30K$31.98M$101.46M$308.29M
High Forecast$2.14M$1.83M$1.40M$46.35M$147.04M$446.80M
Low Forecast$1.82M$1.09M$565.43K$18.70M$59.31M$180.21M
Surprise %28.79%483.42%----

Net Income Forecast

$-350M $-280M $-210M $-140M $-70M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-123.28M$-182.82M$-303.27M---
Avg Forecast$-123.28M$-67.22M$-75.24M$-85.53M$-66.14M$-15.63M
High Forecast$-92.52M$-66.40M$-58.53M$-43.59M$-19.92M$-7.19M
Low Forecast$-164.62M$-68.04M$-91.95M$-127.47M$-112.35M$-24.76M
Surprise %-171.96%303.07%---

PRAX Forecast FAQ

Is Praxis Precision Medicines stock a buy?

Praxis Precision Medicines stock has a consensus rating of Buy, based on 16 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Praxis Precision Medicines is a favorable investment for most analysts.

What is Praxis Precision Medicines's price target?

Praxis Precision Medicines's price target, set by 16 Wall Street analysts, averages $607.15 over the next 12 months. The price target range spans from $162 at the low end to $1.2K at the high end, suggesting a potential 144.84% change from the previous closing price of $247.98.

How does Praxis Precision Medicines stock forecast compare to its benchmarks?

Praxis Precision Medicines's stock forecast shows a 144.84% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Praxis Precision Medicines over the past three months?

  • June 2026: 11.76% Strong Buy, 76.47% Buy, 5.88% Hold, 5.88% Sell, 0% Strong Sell.
  • May 2026: 11.76% Strong Buy, 76.47% Buy, 5.88% Hold, 5.88% Sell, 0% Strong Sell.
  • April 2026: 12.50% Strong Buy, 75.00% Buy, 6.25% Hold, 6.25% Sell, 0% Strong Sell.

What is Praxis Precision Medicines’s EPS forecast?

Praxis Precision Medicines's average annual EPS forecast for its fiscal year ending in December 2026 is $-11.46, marking a -14.99% decrease from the reported $-13.48 in 2025. Estimates for the following years are $-9.52 in 2027, and $-2.37 in 2028.

What is Praxis Precision Medicines’s revenue forecast?

Praxis Precision Medicines's average annual revenue forecast for its fiscal year ending in December 2026 is $31.98M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $101.46M, and $308.29M for 2028.

What is Praxis Precision Medicines’s net income forecast?

Praxis Precision Medicines's net income forecast for the fiscal year ending in December 2026 stands at $-85.528M, representing a -71.80% decrease from the reported $-303M in 2025. Projections indicate $-66.138M in 2027, and $-15.629M in 2028.